Literature DB >> 21499442

Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.

Ryan Chamberlain1, Thomas M Wengenack, Joseph F Poduslo, Michael Garwood, Clifford R Jack.   

Abstract

A major objective in the treatment of Alzheimer's disease is amyloid plaque reduction. Transgenic mouse models of Alzheimer's disease provide a controlled and consistent environment for studying amyloid plaque deposition in Alzheimer's disease. Magnetic resonance imaging is an attractive tool for longitudinal studies because it offers non-invasive monitoring of amyloid plaques. Recent studies have demonstrated the ability of magnetic resonance imaging to detect individual plaques in living mice. This review discusses the mouse models, MR pulse sequences, and parameters that have been used to image plaques and how they can be optimized for future studies.

Entities:  

Year:  2011        PMID: 21499442      PMCID: PMC3076792          DOI: 10.2174/157340511794653522

Source DB:  PubMed          Journal:  Curr Med Imaging Rev        ISSN: 1573-4056


  25 in total

1.  Targeting alzheimer amyloid plaques in vivo.

Authors:  T M Wengenack; G L Curran; J F Poduslo
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

2.  The loss of small objects in variable TE imaging: implications for FSE, RARE, and EPI.

Authors:  R T Constable; J C Gore
Journal:  Magn Reson Med       Date:  1992-11       Impact factor: 4.668

3.  Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.

Authors:  Niels Braakman; Jörg Matysik; Sjoerd G van Duinen; Fons Verbeek; Reinhard Schliebs; Huub J M de Groot; A Alia
Journal:  J Magn Reson Imaging       Date:  2006-09       Impact factor: 4.813

4.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Authors:  Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

5.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

7.  Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.

Authors:  Jiangyang Zhang; Paul Yarowsky; Marcia N Gordon; Giovanni Di Carlo; Sanjay Munireddy; Peter C M van Zijl; Susumu Mori
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.

Authors:  Marc Dhenain; Nadine El Tannir El Tayara; Ting-Di Wu; Maryvonne Guégan; Andreas Volk; Carmen Quintana; Benoît Delatour
Journal:  Neurobiol Aging       Date:  2007-06-27       Impact factor: 4.673

10.  The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

Authors:  William E Klunk; Yanming Wang; Guo-feng Huang; Manik L Debnath; Daniel P Holt; Li Shao; Ronald L Hamilton; Milos D Ikonomovic; Steven T DeKosky; Chester A Mathis
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  9 in total

Review 1.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease.

Authors:  Mark D Meadowcroft; Douglas G Peters; Rahul P Dewal; James R Connor; Qing X Yang
Journal:  NMR Biomed       Date:  2014-12-22       Impact factor: 4.044

3.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Authors:  Linda Zhang; Raymond Chuen-Chung Chang; Leung-Wing Chu; Henry Ka-Fung Mak
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

Review 5.  A review of β-amyloid neuroimaging in Alzheimer's disease.

Authors:  Paul A Adlard; Bob A Tran; David I Finkelstein; Patricia M Desmond; Leigh A Johnston; Ashley I Bush; Gary F Egan
Journal:  Front Neurosci       Date:  2014-10-31       Impact factor: 4.677

6.  Assessment of pathological features in Alzheimer's disease brain tissue with a large field-of-view visible-light optical coherence microscope.

Authors:  Antonia Lichtenegger; Martina Muck; Pablo Eugui; Danielle J Harper; Marco Augustin; Konrad Leskovar; Christoph K Hitzenberger; Adelheid Woehrer; Bernhard Baumann
Journal:  Neurophotonics       Date:  2018-07-24       Impact factor: 3.593

7.  Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.

Authors:  Youssef Zaim Wadghiri; Jialin Li; Jinhuan Wang; Dung Minh Hoang; Yanjie Sun; Hong Xu; Wai Tsui; Yongsheng Li; Allal Boutajangout; Andrew Wang; Mony de Leon; Thomas Wisniewski
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: a histological perspective.

Authors:  Mark D Meadowcroft; James R Connor; Qing X Yang
Journal:  Front Neurosci       Date:  2015-07-23       Impact factor: 4.677

Review 9.  Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer's Disease.

Authors:  Emy Bosseboeuf; Claudio Raimondi
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.